These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 7854910)
1. [Diphtheria prevention among children in Denmark]. Hansen KG; Rønne T Nord Med; 1995; 110(2):48-9, 52. PubMed ID: 7854910 [TBL] [Abstract][Full Text] [Related]
2. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults. Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526 [TBL] [Abstract][Full Text] [Related]
3. [Vaccine protection of Swedish children. Time for revision of replacing doses of diphtheria, tetanus, polio and pertussis]. Olin P Lakartidningen; 2001 Aug; 98(35):3654-7. PubMed ID: 11577639 [TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children. Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age. Nolan T; Bernstein H; Blatter MM; Bromberg K; Guerra F; Kennedy W; Pichichero M; Senders SD; Trofa A; Collard A; Sullivan DC; Descamps D Pediatrics; 2006 Sep; 118(3):e602-9. PubMed ID: 16950952 [TBL] [Abstract][Full Text] [Related]
9. A report of diphtheria surveillance from a rural medical college hospital. Ray SK; Das Gupta S; Saha I J Indian Med Assoc; 1998 Aug; 96(8):236-8. PubMed ID: 9830289 [TBL] [Abstract][Full Text] [Related]
10. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. America Academy of Pediatrics Commitee on Infectious Diseases Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131 [TBL] [Abstract][Full Text] [Related]
11. Contraindications to vaccination in the Russian Federation. Tatochenko V; Mitjushin IL J Infect Dis; 2000 Feb; 181 Suppl 1():S228-31. PubMed ID: 10657219 [TBL] [Abstract][Full Text] [Related]
12. Immunization coverage and immunity to diphtheria and tetanus among children in Hyderabad, India. Murhekar MV; Bitragunta S; Hutin Y; Ckakravarty A; Sharma HJ; Gupte MD J Infect; 2009 Mar; 58(3):191-6. PubMed ID: 19195713 [TBL] [Abstract][Full Text] [Related]
13. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR; Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582 [TBL] [Abstract][Full Text] [Related]
14. Epidemic diphtheria in the 1990s: Azerbaijan. Vitek CR; Velibekov AS J Infect Dis; 2000 Feb; 181 Suppl 1():S73-9. PubMed ID: 10657195 [TBL] [Abstract][Full Text] [Related]
16. Ukraine, 1992: first assessment of diphtheria vaccine effectiveness during the recent resurgence of diphtheria in the Former Soviet Union. Chen RT; Hardy IR; Rhodes PH; Tyshchenko DK; Moiseeva AV; Marievsky VF J Infect Dis; 2000 Feb; 181 Suppl 1():S178-83. PubMed ID: 10657210 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adults. Chan SH; Tan PT; Han HH; Bock HL Singapore Med J; 2006 Apr; 47(4):286-90. PubMed ID: 16572239 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine. Tejedor JC; Moro M; Ruiz-Contreras J; Castro J; Gómez-Campderá JA; Navarro ML; Merino JM; Martín-Ancel A; Roca J; García-del-Río M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Boceta R; García-Corbeira P; Jacquet JM; Collard A; Schuerman L; Pediatr Infect Dis J; 2006 Aug; 25(8):713-20. PubMed ID: 16874171 [TBL] [Abstract][Full Text] [Related]
19. Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: safety, immunogenicity and persistence of antibody responses. Heininger U; ; ; Sänger R; Jacquet JM; Schuerman L Vaccine; 2007 Jan; 25(6):1055-63. PubMed ID: 17049692 [TBL] [Abstract][Full Text] [Related]
20. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine. Langley JM; Predy G; Guasparini R; Law B; Diaz-Mitoma F; Whitstitt P; Tapiero B; Dionne M; Tomovici A; Mills E; Halperin SA Vaccine; 2007 Jan; 25(6):1121-5. PubMed ID: 17045366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]